Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1455.8000 5.90 (0.41%)
NSE Apr 10, 2026 14:09 PM
Volume: 60,159
 

1455.80
0.41%
Motilal Oswal
After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.
Ipca Laboratories Ltd. is trading above its 200 day SMA of 1420.8
More from Ipca Laboratories Ltd.
Recommended